TicoVac and TicoVac Junior Tick-Borne Encephalitis Vaccine (whole Virus inactivated)

 

TicoVac

TicoVac 0.5 ml is indicated for the active (prophylactic) immunisation of persons of 16 years of age and older against tick-borne encephalitis (TBE).

TicoVac 0.5 ml is to be given on the basis of official recommendations regarding the need for, and timing of, vaccination against TBE. 

Refer to Summary of Product Characteristics for TicoVac. 

TicoVac Junior

TicoVac Junior 0.25 ml is indicated for the active (prophylactic) immunisation of children aged from 1 year to 15 years against tick-borne encephalitis (TBE).

TicoVac Junior 0.25 ml is to be given on the basis of official recommendations regarding the need for, and timing of, vaccination against TBE. 

Refer to Summary of Product Characteristics for TicoVac Junior. 

 

For more information on Tick Borne Encephalitis and TicoVac, please visit www.tickalert.org and Pfizer Vaccines. 

PP-TCV-GBR-0050 Date of Preparation: June 2018